Blog Details

Nobel Biocare Unveils Latest Innovations in Implant Technology


Always at the forefront of implant technology, Nobel Biocare is poised to once again open a new chapter in implant dentistry with its Nobel Biocare N1 implant system. This latest innovation was unveiled before more than 1,200 dental professionals at the recent Nobel Biocare Global Symposium in Madrid. 


The new implant system, which will soon be available worldwide, is designed to make treatment times faster and more straightforward, while increasing predictability and enhancing patient comfort. Addressing some of the shortcomings of current protocols, Nobel Biocare N1 was created from over 5 years of scientific and clinical refinement. Going beyond a new implant design, Nobel Biocare is redefining site preparation with the introduction of the OsseoShaper, an alternative to conventional drilling protocols. 

The introduction of the new implant system was a highlight of the annual symposium, which serves as a unique learning experience for the attendees and a celebration of innovation, fueled by the expertise of over 70 world-class researchers and clinicians. The Nobel Biocare N1 system, available for the attendees to see and try out, left an impression on the sold-out audience. 


“I am sure that, in the future, other manufacturers will try to mimic this development, as has been the case for many other innovations—NobelActive, the All-on-4 treatment concept, Immediate Function...the list goes on. But at Nobel Biocare, we follow no one,” said Nobel Biocare President Hans Geiselhöringer.


More information about the Nobel Biocare N1 system and when it will become available can be found here.


In addition to Nobel Biocare N1 , participants were informed about the DTX Studio ecosystem—now connecting treatments from beginning to end—as well as Nobel Biocare’s latest surface innovations, the Xeal abutment surface and the TiUltra implant surface. With their unique surface chemistry and topography, Xeal and TiUltra are designed to optimize early tissue integration and long-term tissue stability. The scientific evidence for these advancements in Mucointegration was recently highlighted in a supplement of the journal, Clinical Implant Dentistry and Related Research. You can find more information here


The Global Symposium also saw a fundamental revitalization of Nobel Biocare’s brand identity and the launch of a new website, boasting a bold new look and feel. “This is a true reflection of our culture. All we do—every product, every process, every solution, every initiative—is guided by our determination to innovate and meet the unmet needs of our customers and their patients,” said Geiselhöringer.

Nobel Biocare President Hans Geiselhöringer addresses attendees.

COMMENTS Post a Comment

No comments